We are live on ! Find out more
LCGLA

LYNX CAPITAL GROUP LTD /ADV Portfolio holdings

AUM $248M
This Fund
S&P 500
This Quarter Est. Return
+7.95%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$148M
AUM Growth
+$10.9M
Cap. Flow
+$816K
Cap. Flow %
0.55%
Top 10 Hldgs %
29.7%
Holding
82
New
1
Increased
37
Reduced
19
Closed
3

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$645K
2
IHI icon
iShares US Medical Devices ETF
IHI
+$519K
3
RSP icon
Invesco S&P 500 Equal Weight ETF
RSP
+$371K
4
ZTS icon
Zoetis
ZTS
+$360K
5
IAU icon
iShares Gold Trust
IAU
+$336K

Top Sells

Rank Stock Value
1
ARES icon
Ares Management
ARES
+$1.2M
2
AVGO icon
Broadcom
AVGO
+$543K
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$265K
4
NVO
Novo Nordisk
NVO
+$210K
5
XLK icon
State Street Technology Select Sector SPDR ETF
XLK
+$186K

Sector Composition

Rank Sector Weight
1 Healthcare 13.83%
2 Financials 13.21%
3 Technology 11.25%
4 Real Estate 4.12%
5 Communication Services 3.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACN icon
26
Accenture
ACN
$109B
$2.52M 1.7%
7,269
+493
+7% +$180K
KO icon
27
Coca-Cola
KO
$376B
$2.49M 1.68%
40,623
+2,458
+6% +$148K
MDT icon
28
Medtronic
MDT
$116B
$2.45M 1.65%
28,107
+1,157
+4% +$98.7K
JNJ icon
29
Johnson & Johnson
JNJ
$632B
$2.44M 1.64%
15,393
+824
+6% +$131K
DIS icon
30
Walt Disney
DIS
$181B
$2.42M 1.63%
19,760
+858
+5% +$89.6K
RTX icon
31
RTX Corp
RTX
$297B
$2.39M 1.61%
24,478
+414
+2% +$37.4K
PG icon
32
Procter & Gamble
PG
$335B
$2.36M 1.59%
14,540
+323
+2% +$50.7K
ABT icon
33
Abbott
ABT
$193B
$2.35M 1.59%
20,704
+1,075
+5% +$123K
SAIC icon
34
Saic
SAIC
$5.35B
$2.32M 1.57%
17,783
+1,366
+8% +$181K
CVS icon
35
CVS Health
CVS
$121B
$2.28M 1.54%
28,544
+3,745
+15% +$286K
ENB icon
36
Enbridge
ENB
$112B
$2.26M 1.53%
62,580
+7,546
+14% +$268K
ZTS icon
37
Zoetis
ZTS
$31.3B
$2.24M 1.51%
13,210
+1,920
+17% +$360K
CVX icon
38
Chevron
CVX
$388B
$2.19M 1.48%
13,865
+2,050
+17% +$309K
PFE icon
39
Pfizer
PFE
$153B
$1.96M 1.32%
70,578
+23,242
+49% +$645K
NVO
40
Novo Nordisk
NVO
$205B
$1.7M 1.15%
13,252
-1,760
-12% -$210K
AAPL icon
41
Apple
AAPL
$4.46T
$1.52M 1.03%
8,885
-48
-0.5% -$8.73K
MCHP icon
42
Microchip Technology
MCHP
$42.2B
$1.48M 1%
16,477
+406
+3% +$35K
AGG icon
43
iShares Core US Aggregate Bond ETF
AGG
$138B
$1.45M 0.98%
14,798
+591
+4% +$57.8K
TLT icon
44
iShares 20+ Year Treasury Bond ETF
TLT
$40.8B
$1.43M 0.96%
15,061
+1
+0% +$95
RQI icon
45
Cohen & Steers Quality Income Realty Fund
RQI
$1.69B
$1.25M 0.85%
103,854
-1,806
-2% -$21.5K
XLRE icon
46
State Street Real Estate Select Sector SPDR ETF
XLRE
$8.68B
$1.24M 0.84%
31,300
– –
KKR icon
47
KKR & Co
KKR
$103B
$1.13M 0.76%
11,187
– –
LQD icon
48
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$32.8B
$1.07M 0.72%
9,854
+1
+0% +$109
BSX icon
49
Boston Scientific
BSX
$74.9B
$1.05M 0.71%
15,325
– –
VRP icon
50
Invesco Variable Rate Preferred ETF
VRP
$3.01B
$947K 0.64%
39,839
+637
+2% +$15K
1
2
3 4

Similar funds

BFM
Blacksheep Fund Management Co. Dublin, Ireland $247M AUM 8.75% 1-Year Est. Return
TAM
Tabor Asset Management New York $249M AUM 48.59% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
VPA
Vernal Point Advisors San Francisco, California $246M AUM 12.97% 1-Year Est. Return
MAMHA
MY.Alpha Management HK Advisors Hong Kong $246M AUM 73.75% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
NTCM
Nut Tree Capital Management New York $245M AUM 34.1% 1-Year Est. Return
KC
Kinloch Capital Glen Allen, Virginia $245M AUM 18.26% 1-Year Est. Return

LYNX CAPITAL GROUP LTD /ADV's Q1 2024 Portfolio in Review

As of Q1 2024, LYNX CAPITAL GROUP LTD /ADV held 82 positions worth $148M, up 8% from $137M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Trading was light in Q1 2024: portfolio turnover was 4.9%. LYNX CAPITAL GROUP LTD /ADV opened 1 new position and exited 3, leaving the 82-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Financials and Technology.

  • LYNX CAPITAL GROUP LTD /ADV's largest Q1 2024 buy was Amazon: 1,708 shares worth $308K.
  • LYNX CAPITAL GROUP LTD /ADV added most to Pfizer in Q1 2024, an estimated $645K increase.
  • LYNX CAPITAL GROUP LTD /ADV's biggest Q1 2024 reduction was Ares Management, cutting an estimated $1.2M.
  • LYNX CAPITAL GROUP LTD /ADV fully exited Alphabet (Google) Class C in Q1 2024, selling an estimated $265K.
  • LYNX CAPITAL GROUP LTD /ADV's ten largest holdings make up 30% of its $148M portfolio in Q1 2024.
  • LYNX CAPITAL GROUP LTD /ADV opened 1 new position and closed 3 in Q1 2024.
  • LYNX CAPITAL GROUP LTD /ADV's portfolio value rose 8% quarter-over-quarter to $148M.

Based on LYNX CAPITAL GROUP LTD /ADV's 13F filing for Q1 2024, filed 10 Aug 2026.